Galectin Therapeutics (GALT) Q4 2024 Earnings

Nov 14Confirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-0.24
-0.21
-0.19
-0.16

Details

Expected EPS
-0.2
Actual EPS
-0.18
Surprise EPS
0.02
Surprise Percent
+10%

Description

⁨Galectin Therapeutics⁩ (⁦GALT⁩) has reported earnings of ⁦-0.18⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts